Literature DB >> 20572369

Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.

Suchada Indhavivadhana1, Thanyarat Wongwananuruk, Manee Rattanachaiyanont, Kitirat Techatraisak, Pichai Leerasiri, Prasong Tanmahasamut, Monrudee Popijan.   

Abstract

OBJECTIVE: To determine the prevalence of metabolic syndrome (MS) in reproductive-aged polycystic ovary syndrome (PCOS) Thai women. MATERIAL AND
METHOD: A Cross sectional study was done at the Gynecologic Endocrinology Unit, Department of Obstetrics and Gynecology, Faculty of Medicine Siriraj Hospital of 250 PCOS Thai women who were diagnosed using Revised Rotterdam 2003 criteria, and who did not take medications affecting sex hormones or lipid metabolism, and attended the Gynecologic Endocrinology Unit between May 2007 and January 2009. Patents were interviewed and examined for weight, height, waist circumference, and blood pressure. Venous blood sample of each patient was drawn after 12-hour fasting. Prevalence of MS determined using the definitions of National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), International Diabetes Federation (IDF), and National Heart Lung and Blood Institutes/American Heart Association (NHLBI/AHA).
RESULTS: Mean +/- SD of age, body mass index (BMI), and waist circumference (WC) were 25.4 +/- 5.8 years, 26.2 +/- 7.6 kg/M2, and 82.3 +/- 16.3 cm, respectively. Prevalence of MS by the definitions of NCEP ATP III, IDF and NHLBI/AHA was 18.0%, 21.2%, and 21.2%, respectively. Of non-MS women, > 40% already had one to two criteria of IDF definition. Among MS women, 100% had central obesity, 50.9% had high blood pressure, 28.3% had impaired fasting blood glucose, 62.3% had hypertriglyceridemia, and 92.5% had high-density lipoprotein cholesterol < 50 mg/dL. The prevalence of MS increased from 10.3% in women aged < 20 years to 50.0% in those aged > or = 40 years (p of trend = 0.003), and from 0.0% in women with BMI < 23 kg/M2 to 54.5% in those with BMI > or = 30 kg/M2 (p of trend < 0.001).
CONCLUSION: The prevalence of MS in reproductive-aged PCOS Thai women was 18.0% by NCEP ATP III and 21.2% by IDF and NHLBI/AHA. The prevalence varies only little with definitions of diagnostic criteria. The prevalence increases with age and body mass index. Slightly more than 40% of the non-MS PCOS Thai women already had one to two criteria of MS.

Entities:  

Mesh:

Year:  2010        PMID: 20572369

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Assessing and treating insulin resistance in women with polycystic ovarian syndrome.

Authors:  Michael L Traub
Journal:  World J Diabetes       Date:  2011-03-15

2.  Prevalence and clinical predictors of insulin resistance in reproductive-aged thai women with polycystic ovary syndrome.

Authors:  Thanyarat Wongwananuruk; Manee Rattanachaiyanont; Suchada Indhavivadhana; Pichai Leerasiri; Kitirat Techatraisak; Prasong Tanmahasamut; Surasak Angsuwathana; Chongdee Dangrat
Journal:  Int J Endocrinol       Date:  2012-01-12       Impact factor: 3.257

Review 3.  Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?

Authors:  Rajani Dube
Journal:  Avicenna J Med       Date:  2016 Oct-Dec

4.  Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam.

Authors:  Minh Tam Le; Vu Quoc Huy Nguyen; Quang Vinh Truong; Dinh Duong Le; Viet Nguyen Sa Le; Ngoc Thanh Cao
Journal:  Endocrinol Metab (Seoul)       Date:  2018-12

Review 5.  Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Jamal Hallajzadeh; Maliheh Khoramdad; Nahid Karamzad; Amir Almasi-Hashiani; Ali Janati; Erfan Ayubi; Reza Pakzad; Mark J M Sullman; Saeid Safiri
Journal:  J Cardiovasc Thorac Res       Date:  2018-05-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.